Pharmaron Beijing (H Dividend yield

Pharmaron Beijing (H is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Pharmaron Beijing (H is a company from China, and his stocks are publicly traded.

Pharmaron Beijing (H stock dividend

Pharmaron Beijing (H paid a total dividend of 66 million HKD last year, for a market value of 5,809 millions (Market Cap 5,810 millions). Pharmaron Beijing (H dividend per share is 0.33 HKD, and his stock market price 28.90 HKD.

According to the chart below, where dividend yield is displayed, Pharmaron Beijing (H has a dividend yield of 1.14%, lower than the amount offered by both the market average and companies from China. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Pharmaron Beijing (H stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high China dividend stocks list.

Pharmaron Beijing (H Dividend Payout

About the ability of Pharmaron Beijing (H to maintain his current dividend of HKD 0.33 per share, an amount that accounts for 1.14%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Pharmaron Beijing (H payout on ernings is currently 35.87%, which is lower than the market average, but higher than companies of Health Care industry, which are 39.87% and 21.91% respectively. Both figures show that Pharmaron Beijing (H is in a good position to keep maintaining his dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Pharmaron Beijing (H is HKD 1.37 per share, which is higher than the dividend per share paid by the company of HKD 0.33, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Pharmaron Beijing (H, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Pharmaron Beijing (H Dividend History

Below you will find a table with the historical evolution of Pharmaron Beijing (H's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	1.14%	0.33	35.87%	201
2022	0.62%	0.34	30.36%	201
2021	0.31%	0.37	20.33%	134
2020	0.14%	0.18	3.68%	134

*In millions

Pharmaron Beijing (H Stock performance

Finally, last moth Pharmaron Beijing (H showed a return of -14.60% compared to a worldwide -2.16% average, and a -3.16% of Health Care firms. Over the last year, the company obtained a -54.20% versus a worldwide performance of a 0.43%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.